DE60032784D1 - Markerproteine für prostatakrebs - Google Patents

Markerproteine für prostatakrebs

Info

Publication number
DE60032784D1
DE60032784D1 DE60032784T DE60032784T DE60032784D1 DE 60032784 D1 DE60032784 D1 DE 60032784D1 DE 60032784 T DE60032784 T DE 60032784T DE 60032784 T DE60032784 T DE 60032784T DE 60032784 D1 DE60032784 D1 DE 60032784D1
Authority
DE
Germany
Prior art keywords
prostate cancer
marker proteins
patients
subjects
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60032784T
Other languages
English (en)
Other versions
DE60032784T2 (de
Inventor
Tai-Tung Yip
Christine Yip
L Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Aspira Womens Health Inc
Original Assignee
Eastern Virginia Medical School
Ciphergen Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22568045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60032784(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eastern Virginia Medical School, Ciphergen Biosystems Inc filed Critical Eastern Virginia Medical School
Application granted granted Critical
Publication of DE60032784D1 publication Critical patent/DE60032784D1/de
Publication of DE60032784T2 publication Critical patent/DE60032784T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60032784T 1999-10-07 2000-10-06 Markerproteine für prostatakrebs Revoked DE60032784T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15842299P 1999-10-07 1999-10-07
US158422P 1999-10-07
PCT/US2000/027682 WO2001025791A2 (en) 1999-10-07 2000-10-06 Prostate cancer marker proteins

Publications (2)

Publication Number Publication Date
DE60032784D1 true DE60032784D1 (de) 2007-02-15
DE60032784T2 DE60032784T2 (de) 2007-11-08

Family

ID=22568045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032784T Revoked DE60032784T2 (de) 1999-10-07 2000-10-06 Markerproteine für prostatakrebs

Country Status (7)

Country Link
EP (1) EP1224466B1 (de)
JP (1) JP2004500553A (de)
AT (1) ATE350662T1 (de)
AU (1) AU7868300A (de)
CA (1) CA2386669A1 (de)
DE (1) DE60032784T2 (de)
WO (1) WO2001025791A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003532055A (ja) * 2000-03-20 2003-10-28 イースタン バージニア メディカル スクール 前立腺癌マーカー
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
AU2003211157A1 (en) * 2002-02-21 2003-09-09 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
WO2004040316A2 (en) 2002-10-30 2004-05-13 Proteome Sciences Plc. Diagnostic method for transmissible spongiform encephalopathies (prion diseases)
WO2004059320A1 (ja) 2002-12-26 2004-07-15 Nitto Boseki Co., Ltd. 免疫測定法およびそれに用いるキット
CA2526878A1 (en) 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP4568551B2 (ja) * 2004-07-28 2010-10-27 一晃 掛樋 糖たん白質糖鎖の分析方法及び非標識糖鎖の製造方法
JP2008537112A (ja) * 2005-04-07 2008-09-11 モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト 前立腺がんの診断のためのポリペプチドマーカー
EP1922326A4 (de) 2006-03-24 2011-06-01 Phenomenome Discoveries Inc Nützliche biomarker für die diagnose von prostatakrebs und methoden für ihre verwendung
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2012127A3 (de) * 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnosemarkierungen zur Erkennung von Prostatakrebs
CA2798812A1 (en) * 2010-05-21 2011-11-24 Ohmx Corporation Detection of cancer by assaying psa enzymatic activity
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
AU2012257602B2 (en) 2011-05-13 2016-04-28 Electrophoretics Limited Methods and compositions relating to platelet sensitivity
WO2015042493A2 (en) * 2013-09-20 2015-03-26 Ohmx Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
WO2021026172A1 (en) 2019-08-05 2021-02-11 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
EP0975963A1 (de) * 1997-03-11 2000-02-02 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches antigensubstrat
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6300088B1 (en) * 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Also Published As

Publication number Publication date
DE60032784T2 (de) 2007-11-08
AU7868300A (en) 2001-05-10
WO2001025791A3 (en) 2001-12-27
JP2004500553A (ja) 2004-01-08
ATE350662T1 (de) 2007-01-15
EP1224466B1 (de) 2007-01-03
WO2001025791A2 (en) 2001-04-12
CA2386669A1 (en) 2001-04-12
EP1224466A2 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
DE60032784D1 (de) Markerproteine für prostatakrebs
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
WO2002046477A3 (en) Endogenous retroviruses up-regulated in prostate cancer
DK0580596T3 (da) Gen muteret i colorektal cancer hos mennesker
ATE238556T1 (de) Krebsbehandlung
WO1997036535A3 (en) Biomarkers for detection, diagnosis and prognosis of prostate cancer
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
BR0316111A (pt) Métodos para diagnosticar rcc e outros tumores sólidos
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
AU9779498A (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
DE60223176D1 (de) Metallkomplexverbindungen
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
IL151448A0 (en) Proteins
WO2001042792A3 (en) Diagnosis of cervical cancer using marker proteins
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
WO2002023200A3 (en) Human breast cancer biomarkers
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
DE60119731D1 (de) Immunologisches test und satz zur diagnose von prostatadenokarzinom
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
WO2003058198A3 (en) Human breast cancer biomarkers
DE69839846D1 (de) Bestimmung der vorhandenen mengen an cyclin-abhängr bei krebspatienten
WO2001096599A3 (en) Methods for quantitative determination of b-fibronectin in biological fluids and tissues
ATE256682T1 (de) Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation
GR1004636B (el) Προγνωσηατουακαρκινουαμεαχρησηατησαθυμοσινησαβ@α}τβ@bαα

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8331 Complete revocation